John Wilson
-
Meet the Team: 2026 Summer Interns and Mentors
We are proud to welcome our 2026 cohort of summer interns, marking the 15th year of the NSF REU program alongside the continued growth of the Summer Tech Crew, established in 2016. Together, these programs provide students with hands-on research and facility experience that supports innovation in nanoscale science and… Read MoreApr. 17, 2026
-
Spotlight on Zack Wallace: Advancing Personalized Cancer Vaccine Research
Zack Wallace Graduate Student, Biomedical Engineering John Wilson Research Group My interest in biomedical research, specifically cancer, developed during high school. As someone raised in Mississippi, I often would see statistics emphasizing how unhealthy and undereducated my state and the South were. Knowing this and having family members… Read MoreApr. 2, 2026
-
Spotlight Publication: “Potentiating cancer immunotherapies with modular albumin-hitchhiking nanobody–STING agonist conjugates” published in Nature Biomedical Engineering
a, Scheme depicting the concept of an albumin-hitchhiking nanobody–STING agonist conjugate for cancer immunotherapy. Anti-albumin nanobodies conjugated to STING agonists bind to circulating albumin in situ, resulting in improved pharmacokinetics and increased biodistribution to tumour sites that stimulates antitumour innate and adaptive immune responses. b, Computational model of the anti-albumin… Read MoreJan. 20, 2026
-
VINSE Celebrates Faculty Achievements at the 19th Annual Fall Faculty Celebration
On October 13, 2025, the VINSE Fall Faculty Celebration took place to honor and celebrate the remarkable achievements of our community. This annual event not only highlighted individual accomplishments but also fostered a sense of camaraderie among colleagues. WELCOME TO VINSE Andrea Locke | Bryant Spreine… Read MoreOct. 14, 2025
-
VINSE to host 19th Annual VINSE Fall Faculty Celebration on October 13
Join us on Monday, October 13 from 4:00–6:00 PM for the 19th annual VINSE Fall Faculty Celebration. This annual tradition brings together the VINSE community to welcome new members, celebrate faculty promotions, and recognize outstanding accomplishments. Welcome New Members Andrea Locke Bryant… Read MoreAug. 20, 2025
-
2024 NanoDay! Poster Award Winners
Congratulations to the winners of the 2024 VINSE NanoDay! Poster Competition! The 24th annual Nanoscience & Nanotechnology Forum Welcomed over 250 registered participants, representing 24 departments at Vanderbilt and partner institutions and 14 of industry collaborators. A total of 66 posters were presented, highlighting the wide range… Read MoreDec. 6, 2024
-
VINSE Recognizes Faculty Accomplishments in the 18th Annual Fall Faculty Celebration
On October 1, 2024, the VINSE Fall Faculty Celebration took place to honor and celebrate the remarkable achievements of our community. This annual event not only highlighted individual accomplishments but also fostered a sense of camaraderie among colleagues. WELCOME TO VINSE Daniel Gonzales | Janell Lees… Read MoreOct. 2, 2024
-
New nanoparticles boost immune system in mice to fight skin, breast cancer
Contact: Lucas Johnson, lucas.l.johnson@vanderbilt.edu Vanderbilt researchers have developed a set of nanoparticles that stimulate the immune system in mice to fight cancer and may eventually do the same in humans. John T. Wilson The research led by John T. Wilson, associate professor of… Read MoreJul. 31, 2024
-
Spotlight Publication: “Engineering endosomolytic nanocarriers of diverse morphologies using confined impingement jet mixing” published in Nanoscale
Co-first author Hayden Pagendarm is a 4th year PhD student in Biomedical Engineering program advised by Dr. John T. Wilson. His research is focused on the development of novel technologies to induce antigen-specific immune tolerance, with a focus on engineered proteins and extracellular vesicles. Co-first author Payton Stone is… Read MoreFeb. 15, 2024
-
Researcher Highlight: Payton Stone
Payton Stone, 4th year Chemical Engineering Ph.D. Candidate in the Wilson Lab Summary of Research: Peptides, proteins, and nucleic acids make up many of the recently developed cancer immunotherapies, which function by activating intracellular pathways to elicit downstream signaling cascades, which in turn result in robust anticancer immune responses. Read MoreJan. 22, 2024